"Performance" VITAL INNO's annual loss narrowed to RMB 17.688 million, trading suspended

阿斯達克財經網
2026.04.01 02:06

維太創科 (06133.HK) 公佈截至去年 12 月底止全年業績，營業額 6.69 億元人民幣 (下同)，按年跌 37.1%。虧損收窄至 1,768.8 萬元，上年同期蝕 2,100 萬元；每股虧損 2.08 分。不派息。

截至去年底，集團擁有現金及現金等價物約 214 萬元，並有流動負債約 1.14 億元須於報告期末起計未來十二個月內償還。

由於與持續經營基準有關之重大不確定性，核數師發表了無法表示意見之意見。應公司要求，公司股份將自 2026 年 4 月 1 日 (星期三) 上午九時正起在聯交所暫停買賣。

Source: 阿斯達克財經網 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.